Ortho Clinical Diagnostics Holdings plc EBIT

Ortho Clinical Diagnostics Holdings plc (OCDX) currently reports a EBIT of $160M as of April 2022. That compares with $17M in the prior-year period — up 848.5% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Ortho Clinical Diagnostics Holdings plc's EBIT history and peer comparisons.

Ortho Clinical Diagnostics Holdings plc's EBIT increased from $17M to $160M — a 848.5% year-over-year increase (period ending April 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ortho Clinical Diagnostics Holdings plc's EBIT of $160M is lower than the Healthcare sector average of $23B. That is roughly 99.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Ortho Clinical Diagnostics Holdings plc reported $160M in EBIT as of April 2022. That compares with $17M in the prior-year period — up 848.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Ortho Clinical Diagnostics Holdings plc, and consider following OCDX for alerts when major investors trade the stock.